Expand IMMX Menu
IMMX MENU

IMMX Latest Press Releases

-- August 11, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX Globe Newswire 6:23 PM

-- August 6, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX PRNewswire 11:02 PM
IMMX Investors Have Opportunity to Join Immix Biopharma, Inc. Fraud Investigation with SBS Law Business Wire 7:58 PM

-- August 4, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX Globe Newswire 4:49 PM
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference Globe Newswire 9:15 AM

-- July 30, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX PRNewswire 10:01 AM

-- July 20, 2026 --

IMMX INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Immix Biopharma, Inc. Globe Newswire 5:33 PM
IMMX ALERT: Immix Biopharma Investigated for Securities Fraud Violations by Block & Leviton; Investors Should Contact the Firm Globe Newswire 11:47 AM

-- May 22, 2026 --

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock Globe Newswire 5:15 PM

-- May 21, 2026 --

Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock Globe Newswire 6:30 AM

-- April 9, 2026 --

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference Globe Newswire 8:45 AM

-- March 30, 2026 --

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones Globe Newswire 8:45 AM
Market Data Delayed 15 Minutes